enlightenbio is a boutique consultancy providing product strategy and market intelligence to precision medicine industries. Our mission is to help our clients successfully develop, launch, and market exceptional...read more
Category - Precision medicine
Genomenon Raises $20M Series B Financing, Launching a New Era in AI-Powered Genomic Data
Financing led by Beringea and Spring Mountain Capital to fuel continued growth in pharmaceutical and clinical diagnostic markets Genomenon®Inc., an AI-driven genomics company, today announced the completion of a...read more
Enlightenbio Releases New Report – Database of Biomarkers Curated from US Oncology Trials
Palo Alto, CA, January 21, 2022 – The “Database of Biomarkers Curated from Oncology Trials” report has been added to the enlightenbio LLC product offering. This new report provides insights into...read more
PacBio and UCLA Health Announce Research Collaboration for Whole Genome Sequencing in Rare Diseases
Collaboration aims to identify variants not easily detectible by short-read sequencing, increasing diagnostic yield in rare disease patients MENLO PARK, Calif., Dec. 07, 2021 (GLOBE NEWSWIRE) — PacBio (Nasdaq:...read more
